Skip to main content
$183.71 $15.71 (9.4%)

04:00 PM EDT on 05/07/21

BioNTech SE (NASDAQ:BNTX)

CAPS Rating: 4 out of 5

Current Price $183.71 Mkt Cap $44.4B
Open $183.34 P/E Ratio 2,846.01
Prev. Close $183.71 Div. (Yield) $0.00 (0.0%)
Daily Range $175.40 - $185.83 Volume 4,463,142
52-Wk Range $45.08 - $213.15 Avg. Daily Vol. 2,963,765

Caps

How do you think NASDAQ:BNTX will perform against the market?

Add Stock to CAPS Watchlist

All Players

45 Outperform
2 Underperform
 

All-Star Players

5 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:BNTX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

marekz (63.39)
Submitted October 07, 2020

BioNTech has become a clear leader in messenger RNA (mRNA) technology The rapid progress of it's COVID-19 vaccine candidates shows how effective they are, and the limits could boom after any success with COVID. A partnership with Pfeizer in exploding… More

TMFang4apples (64.54)
Submitted December 01, 2020

Great company, but there's no way co-commercialization of bnt162 is going to support a $30 billion valuation once attention for mRNA fizzles. I still haven't seen any sign from mRNA developers that they've found a way to ensure safe long-term dosing,… More

NASDAQ:BNTX VS S&P 500 (SPY)

NASDAQ:BNTX Summary

Fools bullish on NASDAQ:BNTX are also bullish on:

Fools bearish on NASDAQ:BNTX are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about BNTX.

Recs

0
Member Avatar TMFacarchidi (< 20) Submitted: 3/19/2021 11:50:14 AM : Outperform Start Price: $105.62 NASDAQ:BNTX Score: +65.92

Strong technology development on their COVID vaccine positions them to be a strong competitor in the MRNA therapy space.

Recs

0
Member Avatar nyncfl (< 20) Submitted: 2/22/2021 6:04:13 PM : Outperform Start Price: $110.78 NASDAQ:BNTX Score: +56.09

Updates concerning the vaccine continue to improve giving the company additional strength in the industry. The next few months will be exciting given the information continues to be positive. Not to shabby with a 15 B $ income this year

Recs

0
Member Avatar TMFjbonefish (47.66) Submitted: 12/16/2020 6:48:14 PM : Outperform Start Price: $102.64 NASDAQ:BNTX Score: +65.50

I am as excited about the company's other programs for genetically-personalized medicine as I am the COVID vaccine. I think BioNTech is under appreciated as a potential multi-bagger.

Leaderboard

Find the members with the highest scoring picks in BNTX.

Score Leader

TMFSpeyside

TMFSpeyside (87.28) Score: +234.94

The Score Leader is the player with the highest score across all their picks in BNTX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TMFSpeyside 87.28 6/12/2020 Outperform 5Y $49.37 +272.11% +37.17% +234.94 0 Comment
TMFFishBiz 57.19 6/24/2020 Outperform 1Y $53.83 +241.31% +37.70% +203.61 0 Comment
MonkDayTrade < 20 7/16/2020 Outperform 5Y $63.27 +190.36% +32.00% +158.36 0 Comment
Skippynicki 31.79 9/18/2020 Outperform 5Y $67.53 +172.04% +26.21% +145.83 0 Comment
skiener4 53.75 8/27/2020 Outperform 5Y $70.00 +162.44% +21.12% +141.32 0 Comment
PLAZMASTOX 25.09 6/29/2020 Outperform 5Y $65.68 +179.70% +40.03% +139.68 0 Comment
Baxter007007 71.64 6/30/2020 Outperform 5Y $67.83 +170.85% +37.79% +133.06 0 Comment
Dananator < 20 8/6/2020 Outperform 5Y $77.20 +137.97% +26.39% +111.57 0 Comment
BHR 35.96 12/29/2020 Outperform 5Y $84.45 +117.54% +12.92% +104.61 0 Comment
MikeTheShark1 35.97 1/4/2021 Outperform 5Y $85.45 +114.99% +12.47% +102.52 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for BNTX.